Renal Cell Carcinoma
📧 Sign up to get email alerts when something new happens for Renal Cell Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-01-13Clinical Trial Update: A Phase II Study Assessing Stereotactic Radiotherapy in Therapeutic Strategy of Oligoprogressive Renal Cell Carcinoma Metastases [Phase 2]
Phase II clinical trial evaluating stereotactic radiotherapy for oligoprogressive metastases in metastatic renal cell carcinoma; currently r…
-
CLINICAL_TRIALS research · 2026-01-12Clinical Trial Update: Predicting HIF-2α Levels in Clear Cell Kidney Cancer Using Machine Learning
A clinical trial from the First Affiliated Hospital of Fujian Medical University aims to predict HIF-2α levels in renal cell carcinoma (clea…
-
CLINICAL_TRIALS research · 2026-01-09Clinical Trial Update: Consolidative Metastasis and Primary Directed Therapy (MPDT) for Renal Cell Carcinoma (RCC) [NA]
This ClinicalTrials.gov entry outlines a study on consolidative metastasis and primary directed therapy (MPDT) for renal cell carcinoma, whi…
-
CLINICAL_TRIALS research · 2026-01-09Clinical Trial Update: Cabozantinib or Sunitinib Malate in Treating Participants With Metastatic Variant Histology Renal Cell Carcinoma [Phase 2]
Phase 2 clinical trial evaluating cabozantinib or sunitinib malate in patients with metastatic variant histology renal cell carcinoma, inclu…
-
CLINICAL_TRIALS research · 2026-01-09Clinical Trial Update: Ixazomib, Gemcitabine, and Doxorubicin in Treating Patients With Locally Advanced or Metastatic Kidney Cancer [Phase 2]
A Phase 2 clinical trial update evaluating ixazomib, gemcitabine, and doxorubicin in locally advanced or metastatic renal cell carcinoma, in…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-01-08Clinical Trial Update: The Cold Ischemia Robot-assisted Partial Nephrectomy [NA]
This clinical trial update notes ongoing recruitment for a robotic, cold-ischemia partial nephrectomy to treat renal cell carcinoma.
-
CLINICAL_TRIALS research · 2026-01-08Clinical Trial Update: A Multicenter Real-World Study on TKI Therapy After Progression on First-Line TKI/IO Therapy or TKI/IO Therapy After Progression on First-Line TKI in Chinese Patients With Metastatic Renal Cell Carcinoma (mRCC)
Clinical trial assessing second-line TKI therapy in Chinese patients with metastatic renal cell carcinoma after progression on first-line TK…
-
CLINICAL_TRIALS research · 2026-01-06Clinical Trial Update: Radical Nephrectomy With vs Without Template Lymph Node Dissection in High-Risk Renal Cell Carcinoma (T-LND RCC): A Randomized Clinical Trial [NA]
The document outlines a randomized clinical trial comparing radical nephrectomy with template lymph node dissection versus without it in hig…
-
CLINICAL_TRIALS research · 2026-01-05Clinical Trial Update: Positron Emission Tomography (PET) Guided Stereotactic Body Radiation Therapy for the Treatment of Oligoprogressive Non-small Cell Lung Cancer, Melanoma, and Renal Cell Carcinoma [Phase 2]
A Phase 2 clinical trial is evaluating PET-guided stereotactic body radiation therapy for oligoprogressive disease in non-small cell lung ca…
-
CLINICAL_TRIALS research · 2025-12-30Clinical Trial Update: TFE Renal Cell Carcinoma: A Prospective Registry and Translational Research Initiative
A prospective registry and translational research initiative on TFE renal cell carcinoma, sponsored by Children's Hospital Medical Center, C…
-
CLINICAL_TRIALS research · 2025-12-29Clinical Trial Update: PET/MR for Characterization of Renal Masses (RMs)
Clinical trial evaluating PET/MR imaging to characterize renal masses is currently recruiting, including renal cell carcinoma and benign ren…
-
CLINICAL_TRIALS research · 2025-12-26Clinical Trial Update: Observational Basket Trial to Collect Tissue to Develop and Train a Live Tumor Diagnostic Platform
An observational basket trial sponsored by Elephas aims to collect tissue to develop and train a live tumor diagnostic platform across multi…
-
CLINICAL_TRIALS research · 2025-12-24Clinical Trial Update: Study on the Diagnostic Value of Novel PET Molecular Imaging for Renal Cell Carcinoma [NA]
A clinical trial is evaluating the diagnostic value of a novel PET molecular imaging agent for renal cell carcinoma and is currently recruit…
-
CLINICAL_TRIALS research · 2025-12-23Clinical Trial Update: Pre-Surgical Sutent in Renal Cell Carcinoma (RCC) [Phase 2]
An update on a Phase 2 trial of pre-surgical sunitinib (Sutent) for renal cell carcinoma. The study is currently active but not recruiting.
-
CLINICAL_TRIALS research · 2025-12-22Clinical Trial Update: The HistoSonics Edison™ System for Treatment of Primary Solid Renal Tumors Using Histotripsy (#HOPE4KIDNEY) [NA]
This entry provides an update on the ongoing clinical trial NCT05820087 evaluating the Edison system from HistoSonics for treating primary s…
-
CLINICAL_TRIALS research · 2025-12-19Clinical Trial Update: Contrast-enhanced Ultrasound and Super-resolution Imaging Predict Renal Function Outcome After Nephrectomy
A clinical trial is investigating whether contrast-enhanced ultrasound and super-resolution imaging can predict renal function outcomes afte…
-
CLINICAL_TRIALS research · 2025-12-19Clinical Trial Update: A Study of Toripalimab in Adjuvant Therapy After Resection of High-risk Renal Cancer [Phase 2]
Phase 2 study evaluating toripalimab as adjuvant therapy after surgical resection of high-risk renal cell carcinoma.
-
CLINICAL_TRIALS research · 2025-12-19Clinical Trial Update: Targeted Abdominal CT in Conjunction With Lung Cancer Screening [NA]
University of Cambridge is recruiting for a study evaluating targeted abdominal CT in conjunction with lung cancer screening. The conditions…
-
CLINICAL_TRIALS research · 2025-12-18Clinical Trial Update: A Study of Belzutifan (MK-6482) as Monotherapy and in Combination With Lenvatinib (E7080/MK-7902) With or Without Pembrolizumab (MK-3475) in China Participants With Advanced Renal Cell Carcinoma (MK-6482-010) [Phase 1]
Phase 1 study of belzutifan as monotherapy and in combination with lenvatinib, with or without pembrolizumab, in Chinese participants with a…
-
CLINICAL_TRIALS research · 2025-12-18Clinical Trial Update: Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist) [Phase 1, Phase 2]
This clinical trial update describes a Phase 1/2 study of INBRX-106 in combination with pembrolizumab for locally advanced or metastatic sol…
-
CLINICAL_TRIALS research · 2025-12-17Clinical Trial Update: Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors [Phase 1]
Clinical trial update for a Phase 1 study evaluating the safety and pharmacokinetics of ADU-1805 in adults with advanced solid tumors; the s…
-
CLINICAL_TRIALS research · 2025-12-17Clinical Trial Update: Axitinib With or Without Anti-OX40 Antibody PF-04518600 in Treating Patients With Metastatic Kidney Cancer [Phase 2]
Phase 2 trial evaluating axitinib with or without the anti-OX40 antibody PF-04518600 for metastatic renal cell carcinoma, currently active a…
-
CLINICAL_TRIALS research · 2025-12-16Clinical Trial Update: Stereotactic Body RadioTherapy With Continuous Tracking for Primary and Secondary Renal Cancer [NA]
A ClinicalTrials.gov registry entry for a trial evaluating stereotactic body radiotherapy with continuous tracking for primary and metastati…
-
CLINICAL_TRIALS research · 2025-12-11Clinical Trial Update: Iparomlimab and Tuvonralimab Injection in Combination With Lenvatinib or Axitinib for the Treatment of Locally Advanced or Metastatic Clear Cell Renal Cell Carcinoma That Has Failed First-Line Systemic Therapy [Phase 2]
Phase 2 clinical trial update evaluating iparomlimab and tuvonralimab in combination with lenvatinib or axitinib for locally advanced or met…
-
CLINICAL_TRIALS research · 2025-12-11Clinical Trial Update: Renal Cancer Monitoring Based on ctDNA Methylomics: A Prospective Cohort Study (MEMORY Study)
A prospective cohort study led by Jinling Hospital in China is evaluating renal cancer monitoring through ctDNA methylomics, with recruitmen…